Israel court dismisses Taro appeal; lifts injunction on Sun tender offer
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries has edged closer to resolving its long-running takeover dispute against Taro Pharmaceutical Industries after the Supreme Court of Israel dismissed Taro's appeal against a previous ruling by the Tel Aviv District Court that held that the Israeli special tender offer (STO) rules do not apply to Sun's tender offer.